Correction to: Efficacy, Safety, and Tolerability of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis.
Inflamm Bowel Dis
; 28(12): 1938, 2022 Dec 01.
Article
em En
| MEDLINE
| ID: mdl-35489068
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article